Olanzapine Glenmark

Medicinal product

(Invented) name

Olanzapine Glenmark

Active substance (s)

Olanzapinas

Strength

20 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH03, Olanzapine

Marketing authorisation holder

Glenmark Arzneimittel GmbH, Vokietija

Date of authorisation

2009-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Olanzapinas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
38829	52511	1052511	lizdinė plokštelė	N28		Receptinis	EU/1/09/587/016	Netiekiama	-	-	No	-	-
38830	52512	1052512	lizdinė plokštelė	N35		Receptinis	EU/1/09/587/017	Netiekiama	-	-	No	-	-
100862	86973	1086973	lizdinė plokštelė	N56		Receptinis	EU/1/09/587/018	Netiekiama	-	-	No	-	-
100863	86974	1086974	lizdinė plokštelė	N70		Receptinis	EU/1/09/587/019	Netiekiama	-	-	No	-	-
100864	86975	1086975	lizdinė plokštelė	N98		Receptinis	EU/1/09/587/025	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-12-03	Registruotas